Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $397
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Medpace Holdings (NASDAQ:MEDP) while lowering the price target from $415 to $397.
October 14, 2024 | 2:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on Medpace Holdings and lowered the price target from $415 to $397, indicating a cautious outlook.
The Hold rating suggests that the analyst does not see significant upside potential in the short term. The lowered price target from $415 to $397 indicates a more conservative outlook on the stock's future performance, which could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100